Keyphrases
Multiple Myeloma
82%
Tumor Necrosis Factor-α
82%
Chemotherapy
67%
Tumor
62%
Successful Treatment
49%
Chronic Myeloid Leukemia
41%
Older Men
41%
Bone Marrow
36%
Docetaxel
35%
Induced Apoptosis
35%
Cytotoxicity
35%
Myeloma Cells
35%
Phase II Study
34%
Older Women
34%
Acute Myeloid Leukemia
34%
Hepatocellular Carcinoma
33%
Apoptosis
32%
Leukemic Cells
32%
5-fluorouracil (5-FU)
31%
Myelodysplastic Syndrome
30%
Malignant Lymphoma
30%
Graft-versus-host Disease (GvHD)
29%
Diffuse Large B-cell Lymphoma (DLBCL)
29%
Neutropenia
28%
Adriamycin
27%
Adenovirus
27%
Combination Chemotherapy
27%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
26%
Liposomes
25%
Cisplatin
25%
TNF Receptor 1 (TNFR1)
25%
Complete Response
24%
Fucose
24%
Tumor Cells
23%
Cyclosporine
23%
Rituximab
23%
Hematopoietic Stem Cell Transplantation
22%
Lenalidomide
21%
Esophageal Cancer
21%
Non-Hodgkin Lymphoma
21%
Complete Remission
21%
Granulocyte Colony-stimulating Factor (G-CSF)
21%
Liver
20%
Human Mesenchymal Stem Cells (hMSCs)
20%
T Cells
20%
Gemcitabine
20%
Lymphoma Cells
19%
Resistance Factor
19%
Binding Activity
19%
Prednisolone
19%
Myelofibrosis
19%
Hepatitis B Virus
19%
Nonalcoholic Steatohepatitis
19%
Stromal Cells
18%
Transforming Growth Factor-β
18%
Phase II Trial
18%
Hematopoietic Stem Cells
18%
Cyclophosphamide
18%
Young Males
18%
Reactive Oxygen Species
18%
Japanese Patients
17%
Metastatic Colorectal Cancer (mCRC)
17%
Histone Deacetylase Inhibitor (HDACi)
17%
Transfectant
17%
Anemia
17%
Colorectal Cancer
17%
Bortezomib
17%
Intracellular Resistance
16%
CD34+ Cells
16%
Heat Shock Factor 1 (HSF1)
16%
Heat Shock Element
16%
Metastatic Potential
16%
Pancreatic Carcinoma Cells
16%
Dasatinib
16%
Deferasirox
16%
Gene Transfer
16%
Small Interfering RNA (siRNA)
16%
Doxorubicin
16%
Virus
16%
Collagen
16%
CDDP
15%
Deep Molecular Response
15%
Leukemia Patients
15%
Thrombocytopenia
15%
Gene Therapy
15%
Corticosteroids
15%
Overall Survival
15%
Metastasis
15%
Autopsy Cases
15%
Antitumor Activity
14%
Lymphoma
14%
Chemoradiotherapy
14%
Allogeneic Peripheral Blood Stem Cell Transplantation
14%
Anticancer Drugs
14%
Fucosylation
13%
Receptor Gene
13%
Systemic Chemotherapy
13%
Hemophagocytic Syndrome
13%
Pure Red Cell Aplasia
13%
Minimal Residual Disease
13%
Medicine and Dentistry
Neoplasm
100%
Chemotherapy
83%
Multiple Myeloma
68%
Acute Myeloid Leukemia
51%
Hepatocellular Carcinoma
37%
Metastatic Carcinoma
30%
Diffuse Large B-Cell Lymphoma
29%
Lymphoma
29%
Chronic Myelogenous Leukemia
29%
Myelodysplastic Syndrome
28%
Lymphoma Cell
27%
Disease
25%
T Cell
24%
Graft Versus Host Reaction
24%
Cyclosporine
23%
Adenoviridae
21%
Abdominal Cancer
21%
Cancer Cell
21%
T-Cell Lymphoma
20%
Rituximab
20%
Hepatitis B Virus
19%
Leukemia Cell
18%
Retrospective Study
17%
Hematopoietic Cell
17%
Programmed Cell Death
17%
Tumor Necrosis Factor
17%
Cytotoxicity
16%
Outpatient
16%
Pancreas Cancer
16%
Recurrent Disease
16%
Liver Metastasis
16%
Hematopoietic Stem Cell Transplantation
16%
Hemophagocytic Syndrome
16%
Histone Deacetylase
16%
Intraarterial Drug Administration
16%
Chemoradiotherapy
16%
Liposome
16%
Acute Graft Versus Host Disease
16%
Myeloma Cell
16%
Leukemia
15%
Promoter Region
14%
Granulocyte Colony Stimulating Factor
14%
In Vitro
14%
Carcinoma
14%
Overall Survival
14%
Prednisolone
14%
Bone Marrow Biopsy
14%
Combination Chemotherapy
13%
Nonalcoholic Fatty Liver
13%
Minimal Residual Disease
13%
Pure Red Cell Aplasia
13%
Drug Resistance
13%
Fucose
13%
Non-Hodgkin Lymphoma
13%
Adverse Event
13%
Colon
13%
Endoscopic Ultrasound
12%
Myelofibrosis
12%
Stromal Cell
12%
Malignant Neoplasm
12%
Ascites
12%
Diagnosis
12%
Arm
12%
Anemia
12%
Cytarabine
12%
Infection
12%
Doxorubicin
12%
Lung Metastasis
12%
Regulatory T Cell
12%
Hedgehog Signaling
12%
Peripheral T-Cell Lymphoma
11%
Biopsy Technique
11%
Cell Death
11%
Liver Cirrhosis
11%
Monotherapy
11%
Acute Lymphoblastic Leukemia
11%
Ex Vivo
11%
Allogeneic Hematopoietic Stem Cell Transplantation
11%
Carfilzomib
11%
Biological Marker
11%
Fanconi Syndrome
10%
Nilotinib
10%
Metastatic Colorectal Cancer
10%
Docetaxel
10%
Plerixafor
10%
Patient with Non-Hodgkins Lymphoma
10%
Autologous Peripheral Blood Stem Cell Transplantation
10%
Mesenchymal Stem Cell
10%
Receptor Antibody
10%
Deferasirox
10%
Phototherapy
10%
B-Cell Chronic Lymphocytic Leukemia
10%
DNA Damage
10%
Enteropathy
10%
Embolization
10%
Cancer Growth Factor
10%
Melanoma
10%
Nanoparticle
10%
Lenalidomide
10%
Cholangiocarcinoma
10%
Pharmacology, Toxicology and Pharmaceutical Science
Tumor Necrosis Factor
94%
Chemotherapy
88%
Neoplasm
68%
Multiple Myeloma
68%
Cytotoxicity
52%
Doxorubicin
40%
Docetaxel
38%
Abdominal Cancer
38%
Remission
34%
Acute Myeloid Leukemia
32%
Myelodysplastic Syndrome
30%
Chronic Myeloid Leukemia
27%
Cisplatin
25%
Neutropenia
24%
Tumor Necrosis Factor Receptor
23%
Disease
23%
Liver Cell Carcinoma
22%
Pancreas Carcinoma
21%
Liposome
21%
Adverse Event
20%
Fluorouracil
19%
Retrospective Study
19%
R-Factor
19%
Nonalcoholic Fatty Liver
19%
Anticarcinogen
18%
Overall Survival
18%
Pancreas Cancer
18%
Superoxide Dismutase
17%
Esophagus Cancer
16%
Metastatic Colorectal Cancer
16%
Heat Shock Transcription Factor 1
16%
Digestive System Cancer
16%
Deferasirox
16%
Gene Delivery
16%
Chemoradiation Therapy
16%
Small Interfering RNA
16%
Leukemia
15%
Cyclophosphamide
15%
Bortezomib
14%
Myeloma
14%
Reactive Oxygen Metabolite
14%
Progression Free Survival
13%
Nonhodgkin Lymphoma
13%
Hepatitis B Virus
13%
Histone Deacetylase Inhibitor
13%
Drug Resistance
13%
Imatinib
13%
Messenger RNA
13%
Fucose
13%
Malignant Neoplasm
13%
Chaperone
12%
Heat Shock Protein 47
12%
Carfilzomib
12%
Normal Human
12%
Denosumab
12%
Receptor
11%
Oxaliplatin
11%
Combination Therapy
11%
Lymphoma
11%
Cytarabine
11%
Thrombocytopenia
11%
Iron Chelating Agent
11%
Nanoparticle
10%
Fanconi Renotubular Syndrome
10%
Lenalidomide
10%
Biliary Tract Cancer
10%
Myelofibrosis
10%
Nedaplatin
10%
Heat Shock Protein 72
10%
Gemcitabine
10%
Retinol
10%
Adenoviridae
10%
Liver Cirrhosis
10%
Extracellular Superoxide Dismutase
10%
Dasatinib
10%
Histone Deacetylase
10%
Granulocyte Colony Stimulating Factor
10%
Ciclosporin
10%
Zoledronic Acid
10%
Dexamethasone
10%
Oxygen Radical
9%
Acute Lymphoblastic Leukemia
9%
Vincristine
9%
Transferrin
9%
Cytokine
9%
Soft Tissue Sarcoma
8%
Hedgehog
8%
Colorectal Carcinoma
8%
Inflammatory Disease
8%
Proteasome
8%
Iron Deficiency Anemia
8%
Survival Rate
8%
Carboplatin
7%
Hepcidin
7%
Biological Marker
7%
Protein P53
7%
Thrombopoietin
7%
Liver Fibrosis
7%
Proteinase
6%
Phase II Trials
6%